Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
ID: 360958Type: Posted
Overview

Buyer

Centers for Disease Control - NCEZID (HHS-CDC-NCEZID)

Award Range

$25K - $1M

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360958
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Increasing awareness and knowledge of Alpha-gal Syndrome in the United States." The primary objective of this funding opportunity is to enhance awareness, surveillance, and patient care related to Alpha-gal Syndrome (AGS), an emerging health condition that is not nationally notifiable. The grant seeks to support the formation of a professional association to disseminate knowledge about AGS, create educational resources for both the public and healthcare providers, and conduct enhanced public health surveillance, with a total estimated program funding of $10 million and awards ranging from $25,000 to $1 million. Interested applicants, including bona fide agents, must submit their applications electronically by May 1, 2026, with an anticipated award date of July 1, 2026. For further inquiries, applicants can contact Jeff Borchert at gqx1@cdc.gov or by phone at (970) 221-6494.

    Point(s) of Contact
    Jeff Borchert
    (970) 221-6494
    gqx1@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    US Travelers Health Research, Surveillance, and Outreach Network
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "US Travelers Health Research, Surveillance, and Outreach Network" through a cooperative agreement aimed at enhancing pre-travel health consultations for international travelers. The primary objectives are to increase the proportion of travelers receiving essential health advice and vaccinations before traveling to areas at risk for infectious diseases, thereby improving the quality of healthcare provided during these consultations. Given the rise in international travel and associated health risks, this initiative is crucial for educating travelers on preventive measures against illnesses such as yellow fever and malaria. The total funding available for this program is $3 million, with individual awards ranging from $450,000 to $600,000. Interested applicants, particularly for-profit organizations, should note that applications are due by March 1, 2026, with an estimated award date of September 15, 2026. For further inquiries, contact Amy Yang at AYang@cdc.gov or call 404-718-8836.
    Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Eliminating Parasitic and Neglected Tropical Disease Threats to the United States," aimed at expanding its network of collaborating institutes for research and program support. The initiative seeks to achieve, accelerate, or maintain outcomes for the elimination or control of non-malaria parasitic threats and neglected tropical diseases that impact the health of Americans domestically and internationally. This cooperative agreement has an estimated total program funding of $10 million, with individual awards ranging from $500,000 to $666,667, and is expected to result in three awards. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 1, 2026, and awards anticipated by September 15, 2026.
    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting research proposals through a cooperative agreement to identify and evaluate potential risk factors for Amyotrophic Lateral Sclerosis (ALS). The opportunity encourages studies focusing on various aspects such as military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents, with four distinct funding options available to support both established and exploratory research. This initiative aims to enhance understanding of ALS risk factors, particularly in affected populations, and to analyze biological samples related to the Guamanian ALS cluster. Interested applicants can reach out to Dr. Candis Hunter at ncipcerpo@cdc.gov or by phone at 770-488-1347. The total estimated funding for this program is $7.5 million, with individual awards ranging from $0 to $500,000, and proposals are due by December 1, 2025, with awards expected to be announced by August 28, 2026.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative seeks applications from bona fide agents representing state, territorial, local, and tribal government organizations, with the goal of implementing effective strategies to combat parasitic diseases. The total estimated program funding is $23,750,000, with individual awards ranging from $250,000 to $1,250,000, and a total of 11 awards expected to be made. Interested applicants should note that the application deadline is June 5, 2026, and they can reach out to Jamal Choice, the Project Officer, at 404.718.8228 or via email at qhi2@cdc.gov for further information.
    Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases." This initiative aims to enhance the nation's capacity to prevent, detect, and respond to infectious disease threats by supporting healthcare professionals, systems, and organizations involved in public health and patient care. The program emphasizes strengthening critical infrastructure, workforce training, and emergency response capabilities, particularly focusing on antimicrobial resistance and infection control. With an estimated total funding of $150 million, the CDC anticipates awarding approximately 15 grants, with individual awards ranging from $1 million to $30 million. Interested applicants can contact Trisia Shannon at 404-639-0063 or via email at xki5@cdc.gov, with applications due by April 18, 2026, and project start dates expected by September 30, 2026.
    Enhancing Global Health Security: Strengthening public health surveillance systems for disease detection and preparedness globally
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement opportunity titled "Enhancing Global Health Security: Strengthening public health surveillance systems for disease detection and preparedness globally." This initiative aims to bolster global health security by enhancing public health surveillance systems, improving workforce capabilities, and integrating surveillance data into actionable insights for decision-making. The program is critical for developing regional and country capacities to detect and respond to infectious diseases and other public health threats. The estimated total funding for this opportunity is $15 million, with two awards expected, and applications must be submitted electronically by April 16, 2026. For further inquiries, interested applicants can contact Broderick Yoerg at 404.234.0666 or via email at DGHPNOFOs@cdc.gov.
    Centers of Excellence in Healthcare Quality: Detecting and Responding to Threats to Healthcare Safety
    Centers for Disease Control - NCEZID
    The Centers for Disease Control - NCEZID is offering a federal grant opportunity titled "Centers of Excellence in Healthcare Quality: Detecting and Responding to Threats to Healthcare Safety." This initiative aims to establish a collaborative network among healthcare systems, facilities, and public health partners to enhance the detection, response, and prevention of threats to patient and healthcare worker safety, ultimately improving the quality and resilience of U.S. healthcare delivery. The program is particularly relevant for various healthcare settings, including hospitals, nursing homes, and outpatient facilities, and encourages partnerships with public health departments and relevant entities. Interested applicants can apply for funding ranging from $2.5 million to $15 million, with an estimated total program funding of $750 million and an expected ten awards. Applications must be submitted electronically by June 5, 2026, with the anticipated award date set for August 1, 2026. For further inquiries, applicants may contact Carla Doan at gon5@cdc.gov or by phone at 770-488-8354.
    Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases." This funding opportunity aims to support research projects focused on travel-related illness surveillance and sentinel event detection, with the goal of enhancing the health of U.S. communities and travelers through a collaborative network of travel and tropical medicine providers. The research will connect clinical medicine and public health, addressing critical public health questions to inform guidelines and improve patient care regarding infectious diseases encountered while traveling. The estimated total program funding is $3 million, with individual awards ranging from $450,000 to $600,000, and applications are due by March 1, 2026. For further inquiries, interested applicants can contact Amy Yang at AYang@cdc.gov or by phone at 404-718-8836.
    Enhancing global laboratory systems to safely manage biological risks, deploy diagnostics and sequence pathogens to strengthen health protection worldwide
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at enhancing global laboratory systems to manage biological risks and improve health protection worldwide. The initiative focuses on strengthening public health laboratory systems, workforce development, bio risk management, emergency preparedness, laboratory quality management, and enhancing diagnostic capacities, particularly in low-resource settings. This funding opportunity, with an estimated total program funding of $25 million and expected to award three grants, is open to unrestricted applicants, with applications due by January 2, 2026. For further inquiries, interested parties can contact Broderick Yoerg at 404.234.0666 or via email at DGHPNOFOs@cdc.gov.
    Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations" through a cooperative agreement. This initiative aims to support research that gathers timely economic data on immunization from nationally representative samples of the public, including patients and caregivers, to inform economic evaluations of new vaccines. The program is critical for understanding productivity losses related to immunization, particularly for vulnerable populations such as pregnant women and parents of young children. The estimated total funding for this program is $1.2 million, with individual awards ranging from $300,000 to $400,000. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 31, 2026, and project start anticipated on September 1, 2026.